- Email: [email protected]
Progress in the EEC
British HomteopathicJournal July 1989. Vol. 78. p. 121-122
Our cover
The effect of noradrenalin on a constricted vein. For fuller details see Dr Crotty's article in this issue.
Guest editorial
Progress in the E E C . . .
On 22 November 1988 an International Conference of Hom0eopathic physicians, pharmacists, manufacturers and representatives of patients from the twelve member nations of the European Community convened by the Faculty of Hom0eopathy met at The Royal London Homoeopathic Hospital. The meeting discussed the European Commission's proposal for a Council Directive, laying down provisions for homoeopathic proprietary medicinal products. The Conference in general welcomed the proposal and resolved to examine its detailed provisions further with the Commission and in particular to meet officials of the Directorate General for Internal Market and Industrial Affairs early in 1989. Accompanied by Mr Cornelis, the President of Comit6 International des Pharmaciens Homeopathiques (CIPH) and his colleagues, I met Dr Fernand Sauer, representing the EC Commission, on 9 March 1989. The meeting was satisfactory, but the challenge to the homoeopathic community is still very considerable. We have to agree amongst ourselves on a European homoeopathic pharmacopoeia as quickly as possible. Then we must seek the wider approval of the Council of Europe. Pray note the difference. The twelve member states of the European Community are all members of the much larger Council of Europe. Recently the Community adhered to the Council of Europe's
Convention, establishing the European Pharmacopoeia concerning allopathic medicines. It is suggested that the same procedure be adopted for homoeopathic preparations, namely that the Council of Europe prepare an addition to the existing Convention or create a new Convention for a European homoeopathic pharmacopoeia to which the European Community will adhere. Our colleagues in the Federal Republic of Germany have a nationally recognized homoeopathic pharmacopoeia integrated with the German National Pharmacopoeia since 1978. In France the Homoeopathic Pharmacopoeia has been state-recognized since 1965 and incorporated in the National Pharmacopoeia in January this year. What needs to be done now is to reconcile these two official pharmacopoeias, taking into account the homoeopathic practice and traditions of the other ten countries. This was agreed at the meeting the next day in Brussels of the CIPH. We were very encouraged to witness the enthusiasm of our pharmacist colleagues, drawing up a work programme for the next three months to prepare themselves for the initial informal meeting in Strasbourg, the seat of the Council of Europe, held in May 1989. Of course, many problems remain. Shall we take into account the existing pharmacopoeias in use in other countries outside Europe, such as the United States? What of our colleagues in Latin America and India? Will the ignorance of 121
122 and indifference to homoeopathy in certain European member states, where its practice is few and far between, turn into formal opposition to such a Convention? To ensure an efficient follow-up to all this work and effort it was agreed that a second International Conference will be hosted by The Faculty of Homeeopathy and The Homeeopathic
British Hom~eopathic Journal
Trust in The Royal London Homoeopathic Hospital on 22 June 1989. Provided all of us in the homoeopathic family stick together, we can ensure not only the survival but a flourishing of the practice of homoeopathy in Europe and throughout the world. T H E RT. H O N . DR J . D I C K S O N M A B O N ~ MB~ CHB~ M F H O M , D H M S A
Homeopathy Today An Invitation
Throughout the eighties, 'Hom0eopathy Today', published by The Hahnemann Society (a registered charity whose President is Sir Yehudi Menuhin), has made a significant contribution to the task of keeping homeeopathy in the public eye and championing homeeopathy's rights within the NHS. Its authoritative content and attractive presentation have gained an enthusiastic readership which includes health care professionals and a
wide public with varying degrees of knowledge and experience of homeepathic medicine. The Editors of Homoeopathy Today extend an invitation to readers of the British Homeeopathic Journal to submit articles, case histories and comment for publication. Please send to The Hahnemann Society, Humane Education Centre, Bounds Green Road, London N22 4EU. A specimen copy will be supplied if required.
Our cover
The effect of noradrenalin on a constricted vein. For fuller details see Dr Crotty's article in this issue.
Guest editorial
Progress in the E E C . . .
On 22 November 1988 an International Conference of Hom0eopathic physicians, pharmacists, manufacturers and representatives of patients from the twelve member nations of the European Community convened by the Faculty of Hom0eopathy met at The Royal London Homoeopathic Hospital. The meeting discussed the European Commission's proposal for a Council Directive, laying down provisions for homoeopathic proprietary medicinal products. The Conference in general welcomed the proposal and resolved to examine its detailed provisions further with the Commission and in particular to meet officials of the Directorate General for Internal Market and Industrial Affairs early in 1989. Accompanied by Mr Cornelis, the President of Comit6 International des Pharmaciens Homeopathiques (CIPH) and his colleagues, I met Dr Fernand Sauer, representing the EC Commission, on 9 March 1989. The meeting was satisfactory, but the challenge to the homoeopathic community is still very considerable. We have to agree amongst ourselves on a European homoeopathic pharmacopoeia as quickly as possible. Then we must seek the wider approval of the Council of Europe. Pray note the difference. The twelve member states of the European Community are all members of the much larger Council of Europe. Recently the Community adhered to the Council of Europe's
Convention, establishing the European Pharmacopoeia concerning allopathic medicines. It is suggested that the same procedure be adopted for homoeopathic preparations, namely that the Council of Europe prepare an addition to the existing Convention or create a new Convention for a European homoeopathic pharmacopoeia to which the European Community will adhere. Our colleagues in the Federal Republic of Germany have a nationally recognized homoeopathic pharmacopoeia integrated with the German National Pharmacopoeia since 1978. In France the Homoeopathic Pharmacopoeia has been state-recognized since 1965 and incorporated in the National Pharmacopoeia in January this year. What needs to be done now is to reconcile these two official pharmacopoeias, taking into account the homoeopathic practice and traditions of the other ten countries. This was agreed at the meeting the next day in Brussels of the CIPH. We were very encouraged to witness the enthusiasm of our pharmacist colleagues, drawing up a work programme for the next three months to prepare themselves for the initial informal meeting in Strasbourg, the seat of the Council of Europe, held in May 1989. Of course, many problems remain. Shall we take into account the existing pharmacopoeias in use in other countries outside Europe, such as the United States? What of our colleagues in Latin America and India? Will the ignorance of 121
122 and indifference to homoeopathy in certain European member states, where its practice is few and far between, turn into formal opposition to such a Convention? To ensure an efficient follow-up to all this work and effort it was agreed that a second International Conference will be hosted by The Faculty of Homeeopathy and The Homeeopathic
British Hom~eopathic Journal
Trust in The Royal London Homoeopathic Hospital on 22 June 1989. Provided all of us in the homoeopathic family stick together, we can ensure not only the survival but a flourishing of the practice of homoeopathy in Europe and throughout the world. T H E RT. H O N . DR J . D I C K S O N M A B O N ~ MB~ CHB~ M F H O M , D H M S A
Homeopathy Today An Invitation
Throughout the eighties, 'Hom0eopathy Today', published by The Hahnemann Society (a registered charity whose President is Sir Yehudi Menuhin), has made a significant contribution to the task of keeping homeeopathy in the public eye and championing homeeopathy's rights within the NHS. Its authoritative content and attractive presentation have gained an enthusiastic readership which includes health care professionals and a
wide public with varying degrees of knowledge and experience of homeepathic medicine. The Editors of Homoeopathy Today extend an invitation to readers of the British Homeeopathic Journal to submit articles, case histories and comment for publication. Please send to The Hahnemann Society, Humane Education Centre, Bounds Green Road, London N22 4EU. A specimen copy will be supplied if required.